Quest Diagnostics, Inc.
DGX
Market Cap$14.44B
Close$
$203.48
60.2% upside
Current Fair Value
60.2% upsideUndervalued by 60.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.44 Billion |
|---|---|
| Enterprise Value | $18.60 Billion |
| Dividend Yield | $2.8564 (2.2%) |
| Earnings per Share | $7.52 |
| Beta | 0.18 |
| Outstanding Shares | 111,056,065 |
| Avg 30 Day Volume | 948,054 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 16.99 |
|---|---|
| PEG | 18.85 |
| Price to Sales | 1.53 |
| Price to Book Ratio | 2.27 |
| Enterprise Value to Revenue | 2.01 |
| Enterprise Value to EBIT | 13.99 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.26 |
| Debt to Equity | 0.77 |
Revenue Sources
No data
ESG Score
No data
About Quest Diagnostics, Inc.
47,000 employees
CEO: Stephen Rusckowski Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy beh...